Seres therapeutics reports first quarter 2021 financial results and provides business updates

Cambridge, mass.--(business wire)--seres therapeutics, inc., (nasdaq: mcrb), a leading microbiome company developing a novel class of multifunctional bacterial therapeutics designed to functionally interact with host cells and tissues to treat disease, today reported first quarter 2021 financial results and provided business updates. “we continue to make steady progress across our broad microbiome pipeline and we look forward to an eventful remainder of the year with important clinical mileston
MCRB Ratings Summary
MCRB Quant Ranking